Lilly Reports Strong Fourth-Quarter and Full-Year 2018 Financial Results, Lowers 2019 EPS Guidance to Reflect the Pending Acquisition of Loxo Oncology

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/14/2026

1. NVDA
2. ORCL
3. USO
4. SPY
5. SRRK
6. DFTX
7. AZN
8. CGEM
9. LYNX
10. SATL

Go back to Lilly Reports Strong Fourth-Quarter and Full-Year 2018 Financial Results, Lowers 2019 EPS Guidance to Reflect the Pending Acquisition of Loxo Oncology
eLandia International, Inc. (NYSE: ELAN) Delayed: 23.28 +0.11 (0.47%)
Previous Close $23.17    52 Week High $0.65 
Open $23.50    52 Week Low $0.03 
Day High $23.52    P/E N/A 
Day Low $23.16    EPS $-0.60 
Volume 1,206,652       

Lilly (Eli) & Co. (NYSE: LLY) Delayed: 1144.81 +29.11 (2.61%)
Previous Close $1115.70    52 Week High $88.16 
Open $1142.20    52 Week Low $67.88 
Day High $1153.95    P/E 265.00 
Day Low $1130.50    EPS $4.32 
Volume 1,146,519